Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition
Author(s) -
Andrew M. Waters,
Tala O. Khatib,
Bjoern Papke,
Craig M. Goodwin,
G. Aaron Hobbs,
J. Nathaniel Diehl,
Runying Yang,
A. Cole Edwards,
Katherine H. Walsh,
Rita Sulahian,
James M. McFarland,
Kevin S. Kapner,
Thomas S.K. Gilbert,
Clint A. Stalnecker,
Sehrish Javaid,
Anna Barkovskaya,
Kajal R. Grover,
Priya S. Hibshman,
Devon R. Blake,
Antje Schaefer,
Katherine M. Nowak,
Jennifer E. Klomp,
Tikvah K. Hayes,
Michelle Kassner,
Nanyun Tang,
Olga Tanaseichuk,
Kaisheng Chen,
Yingyao Zhou,
Manpreet Kalkat,
Laura E. Herring,
Lee M. Graves,
Linda Z. Penn,
Hongwei Yin,
Andrew J. Aguirre,
William C. Hahn,
Adrienne D. Cox,
Channing J. Der
Publication year - 2021
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2021.109291
Subject(s) - pancreatic cancer , kras , synthetic lethality , mapk/erk pathway , cancer research , biology , small interfering rna , cancer cell , microbiology and biotechnology , kinase , cancer , mutant , transfection , cell culture , biochemistry , genetics , colorectal cancer , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom